Biologically active secoiridoids: A comprehensive update

Med Res Rev. 2023 Jul;43(4):1201-1252. doi: 10.1002/med.21949. Epub 2023 Mar 10.

Abstract

Secoiridoids are natural products of cyclopentane monoterpene derivatives that are formed by splitting the rings of cyclomethene oxime compounds at C-7 and C-8, and only account for a small part of cyclic ether terpenoids. Because of the chemically active hemiacetal structure in their common basic skeleton, secoiridoids have a wide range of biological activities, such as neuroprotective, anti-inflammatory, antidiabetic, hepatoprotective, and antinociceptive activities. Phenolic secoiridoids can also act against multiple molecular targets involved in human tumorigenesis, making them potentially valuable precursors for antitumor drug development. This review provides a detailed update, covering relevant discoveries from January 2011 to December 2020, about the occurrence, structural diversity, bioactivities, and synthesis of naturally occurring secoiridoids. We aimed to resolve the lack of extensive, specific, and thorough review of secoiridoids, as well as open new areas for pharmacological investigation and better drugs based on these compounds.

Keywords: biological activity; biosynthesis; secoiridoids; structural diversity; synthesis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents
  • Antineoplastic Agents* / pharmacology
  • Humans
  • Iridoids* / chemistry
  • Iridoids* / pharmacology
  • Phenols

Substances

  • Iridoids
  • Phenols
  • Antineoplastic Agents
  • Anti-Inflammatory Agents